Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predicting Type 2 Diabetes and Testosterone Effects in high-risk Australian men: Development and external validation of a 2 year risk model.
Robledo KP, Marschner IC, Grossmann M, Handelsman DJ, Yeap BB, Allan CA, Foote C, Inder WJ, Stuckey BGA, Jesudason D, Bracken K, Keech AC, Jenkins AJ, Gebski V, Jardine M, Wittert G. Robledo KP, et al. Among authors: jesudason d. Eur J Endocrinol. 2024 Dec 25:lvae166. doi: 10.1093/ejendo/lvae166. Online ahead of print. Eur J Endocrinol. 2024. PMID: 39720906
Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial.
Wittert G, Bracken K, Robledo KP, Grossmann M, Yeap BB, Handelsman DJ, Stuckey B, Conway A, Inder W, McLachlan R, Allan C, Jesudason D, Fui MNT, Hague W, Jenkins A, Daniel M, Gebski V, Keech A. Wittert G, et al. Among authors: jesudason d. Lancet Diabetes Endocrinol. 2021 Jan;9(1):32-45. doi: 10.1016/S2213-8587(20)30367-3. Lancet Diabetes Endocrinol. 2021. PMID: 33338415 Clinical Trial.
Effect of Testosterone Treatment on Bone Microarchitecture and Bone Mineral Density in Men: A 2-Year RCT.
Ng Tang Fui M, Hoermann R, Bracken K, Handelsman DJ, Inder WJ, Stuckey BGA, Yeap BB, Ghasem-Zadeh A, Robledo KP, Jesudason D, Zajac JD, Wittert GA, Grossmann M. Ng Tang Fui M, et al. Among authors: jesudason d. J Clin Endocrinol Metab. 2021 Jul 13;106(8):e3143-e3158. doi: 10.1210/clinem/dgab149. J Clin Endocrinol Metab. 2021. PMID: 33693907 Clinical Trial.
Mediation analysis of the testosterone treatment effect to prevent type 2 diabetes in the Testosterone for Prevention of Type 2 Diabetes Mellitus trial.
Robledo KP, Marschner IC, Handelsman DJ, Bracken K, Stuckey BGA, Yeap BB, Inder W, Grossmann M, Jesudason D, Allan CA, Wittert G. Robledo KP, et al. Among authors: jesudason d. Eur J Endocrinol. 2023 Jul 10;188(7):613-620. doi: 10.1093/ejendo/lvad074. Eur J Endocrinol. 2023. PMID: 37406250 Clinical Trial.
Long-term Outcomes of Testosterone Treatment in Men: A T4DM Postrandomization Observational Follow-up Study.
Handelsman DJ, Grossmann M, Yeap BB, Stuckey BGA, Shankara-Narayana N, Conway AJ, Inder WJ, McLachlan RI, Allan C, Jenkins AJ, Jesudason D, Bracken K, Wittert GA. Handelsman DJ, et al. Among authors: jesudason d. J Clin Endocrinol Metab. 2023 Dec 21;109(1):e25-e31. doi: 10.1210/clinem/dgad485. J Clin Endocrinol Metab. 2023. PMID: 37623257 Clinical Trial.
Testosterone Treatment, Weight Loss, and Health-related Quality of Life and Psychosocial Function in Men: A 2-year Randomized Controlled Trial.
Grossmann M, Robledo KP, Daniel M, Handelsman DJ, Inder WJ, Stuckey BGA, Yeap BB, Ng Tang Fui M, Bracken K, Allan CA, Jesudason D, Zajac JD, Wittert GA. Grossmann M, et al. Among authors: jesudason d. J Clin Endocrinol Metab. 2024 Jul 12;109(8):2019-2028. doi: 10.1210/clinem/dgae085. J Clin Endocrinol Metab. 2024. PMID: 38335137 Free PMC article. Clinical Trial.
47 results